Skip to main content

Anti-Rheumatic Rx

RheumNow Podcast square
Dr. Jack Cush reviews and highlights his favorite abstracts and presentations from last week's virtual EULAR 2021 meeting. COSMOS: Guselkumab in TNF-IR PsA. # OP0230m Coates LC, et al. C-OPTIMISE:…
DAPSA PsA measure
Given its multiple domains, there remains much discussion over the best disease activity scoring method in PsA. The proverbial "holy grail" would be a measure that is quick, intuitive, domain…
Video: The PsA SpA Paradox of Choice

Dr. Rachel Tate ( @uptoTate) reviews Dr. Laura Coates' presentation Personalized T

Dr. John Cush RheumNow

1 week ago
Video: The PsA SpA Paradox of Choice Dr. Rachel Tate ( @uptoTate) reviews Dr. Laura Coates' presentation Personalized Treatment Strategies in Psoriatic Arthritis, given at the virtual #EULAR2021 meeting. https://t.co/Yg12SHR1MF https://t.co/UiCYDU5XGc
meeting.audience.3.jpg
Lots of presentations on the last day; notably, the late breaking abstracts and others. Here are a few of my favorites from Day 4. Mavrilimumab in COVID-19: LB0001– Mavrilimumab, (MAV) a human anti…
light-bulbs-1125016_640.jpg
An analysis of SLE samples from SLE 1760 patients with active disease from RCTs illustrated several known and some new targets for SLE treatment (POS0351). Markers of pathways altered in these…
audience learn
Here are a few notable presentations from Day 3. BEAT- LUPUS Trial: OP0129 – I would consider this a pilot trial as it only included 52 patients with active SLE, but the gist was that active SLE…
×